Trending Online CME/CE

Optimizing the Management of Advanced Cervical Cancer With Checkpoint Inhibitor Therapy

NEW ACTIVITY | 1.0 CME/CE | ILNA Points
This case-based online activity features a discussion between leading clinical investigators, Ramez Eskander, MD and Bradley Monk, MD, FACS, FACOG, as they explore the management of advanced cervical cancer with checkpoint inhibitor therapy.

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

NEW ACTIVITY | 1.0 CME | ILNA Points
Watch this CME-certified discussion with Brian I. Rini, MD, FACP from Cleveland Clinic Lerner College of Medicine as he discusses emerging data on targeted therapies for the treatment of patients with advanced RCC.

Nursing Strategies to Optimize Treatment Experiences in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

NEW ACTIVITY | 1.0 CE | ILNA Points
In this CE-certified online activity, Constance Visovsky, PhD, RN, ACNP, FAAN discusses treatment planning, CDK4/6 inhibitor safety profiles, and supportive care strategies for patients with metastatic breast cancer.

Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors

0.8 CE | ILNA Points

In this case-based activity, Pamela Ryan, RN, BSN from Ochsner Medical Center and Donna Williams, RN from Stanford Medicine discuss signs and symptoms of carcinoid syndrome in patients with NETs and the application of supportive care strategies to provide symptom relief.

Preventing and Mitigating Chemotherapy-Induced Nausea and Vomiting in High-Risk Patients

1.0 CE | ILNA Points

In this case-based activity, Rebecca Clark-Snow, RN, BSN, OCN® and Una T. Hopkins, DNP discuss CINV risk assessment, emetic risk, antiemetic regimens, and self report in high-risk patients with cancer.

Defining Personalized Care Plans in Metastatic Castration-Resistant Prostate Cancer

1.0 CME/CE | ILNA Points

Watch this CME/CE-certified discussion with Tanya Dorff, MD from the Keck School of Medicine as she discusses progress in our understanding of predictive/prognostic markers in advanced prostate cancer as well as optimizing treatment sequencing and response assessment.

Selecting Optimal Therapeutic Strategies for Patients With Differentiated and Medullary Thyroid Cancer

1.0 CME | ILNA Points

In this case-based activity, leading clinical investigator Jochen Lorch, MD, MS from Dana-Farber Cancer Institute will share insights into evidence-based personalized care planning for patients with differentiated and medullary thyroid cancer.

Appraisal of Recent Progress in Metastatic Castration-Resistant Prostate Cancer: Current Trends and Future Directions

1.0 CME | ILNA Points

In this case-based activity, leading clinical investigator Oliver Sartor, MD examines recent developments and best practices in treatment selection and supportive care planning for patients with metastatic CRPC.

Nursing Management of Oral Mucositis

1.0 CE | ILNA Points
Oral mucositis is considered one of the most debilitating side effects of cancer therapy. This online activity reviews pathobiology, risk factors, clinical assessment, and supportive care interventions.

Nursing Management of Tumor Lysis Syndrome

1.0 CE | ILNA Points
TLS is an oncological emergency which can result in acute renal failure, cardiac arrhythmias, seizures, and even death. This online activity reviews signs and symptoms, risk factors, and supportive care interventions.

Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy

1.0 CE | ILNA Points
CIPN is a complication of cancer treatment that may lead to permanent nerve damage in severe cases. This online activity reviews causative agents, signs and symptoms, and supportive care interventions.

Nursing Management of Venous Thromboembolism in Hospitalized Patients With Cancer

1.0 CE | ILNA Points
VTE is a life-threatening complication in hospitalized patients with cancer, and is associated with a 2- to 6-fold increase in likelihood of death. This online activity reviews signs and symptoms, risk assessment, and supportive care interventions.

Nursing Management of Venous Thromboembolism in Ambulatory Patients With Cancer

1.0 CE | ILNA Points

VTE is a common and potentially life-threatening complication in patients with cancer. This online activity reviews venous thromboembolism pathophysiology, risk assessment, and supportive care interventions for ambulatory cancer patients.

Management of Cancer Pain: Current Guidelines

1.0 CE | ILNA Points
Pain is among the most debilitating symptoms cancer patients experience. This online activity reviews the pathophysiology of cancer pain and scientific principles of pain management, assessment, and emerging concepts in pharmacological management.

Prevention of Medical Errors in Nursing Practice

1.0 CE | ILNA Points
Medical errors are among the most common health-threatening mistakes that affect patient care. This online activity reviews the categories of medication errors, at-risk patient populations, and best practices in error analysis and reporting.

Nursing Management of Cancer Treatment-Induced Cardiotoxicity

1.0 CE | ILNA
Studies have shown that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. This activity reviews recent advances in the management of treatment-induced cardiotoxicity.

Nursing Management of Bone Health in Patients With Cancer

1.0 CE | ILNA Points
Once it has metastasized to the skeletal system, cancer often negatively affects bone health, leading to pain, fractures, hypercalcemia, and nerve compression. This online activity reviews interventions to reduce morbidity and mortality of bone complications in patients with cancer

CME/CE Meeting Series for Institutions

Challenges and Opportunities in Castration-Resistant Prostate Cancer

1.0 CME/CE/CPE | VA/DoD Meeting Series

This live activity will bring a leading clinical investigator to your VA/DoD medical center to discuss emerging data on treatment selection, resistance, and response in CRPC. Schedule a meeting at your institution today!

Current Challenges and New Opportunities in Follicular Lymphoma

1.0 CME/CE | Visiting Faculty Meeting Series

This live activity will bring a leading clinical investigator to your cancer center to discuss emerging data in treatment selection and supportive care for patients with previously untreated and relapsed/refractory FL. Enroll your institution today!

New Directions in the Management of Recurrent Ovarian Cancer: Focus on PARP Inhibitors

1.0 CME | Visiting Faculty Meeting Series

This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on PARP inhibitors that can rationally inform the management of ovarian cancer. Enroll your institution today!

Company

Resources

Follow Us

© Copyright 2018 i3 Health. All rights reserved.